揿针耳穴联合腧穴在肺癌化疗致顽固性呃逆中的应用效果

Effect of press-needle in auricular points combined with acupoints in treating intractable hiccups induced by chemotherapy for lung cancer

  • 摘要:
      目的  观察揿针耳穴联合腧穴在肺癌化疗致顽固性呃逆中的应用效果。
      方法  将63例肺癌化疗致顽固性呃逆患者随机分为揿针组(n=32)和对照组(n=31)。揿针组采用揿针耳穴联合腧穴治疗,对照组采用盐酸甲氧氯普胺治疗,疗程均为7 d。观察2组治疗前后呃逆评分以及生活质量评分的变化,评价2组的治疗总有效率。
      结果  揿针组治疗3、7 d时呃逆评分低于对照组,差异有统计学意义(P < 0.05)。治疗7 d时,揿针组临床总有效率为93.8%,高于对照组的71.0%,差异有统计学意义(P < 0.05)。治疗7 d时,揿针组精神状态、睡眠、饮食等生活质量评分高于对照组,差异有统计学意义(P < 0.05)。2组不良反应均较少,症状轻微。
      结论  揿针耳穴联合腧穴治疗肺癌化疗致顽固性呃逆的效果较好,可改善患者生活质量。

     

    Abstract:
      Objective  To observe the effect of press-needle in auricular points combined with acupoints in treating intractable hiccups induced by chemotherapy for lung cancer.
      Methods  Totally 63 patients with intractable hiccups caused by chemotherapy for lung cancer were randomly divided into press-needle group (n=32) and control group (n=31). The press-needle group was treated with press-needle therapy in auricular points combined with acupoints, while the control group was treated with metoclopramide hydrochloride, and both groups were treated for 7 days. The changes of hiccup score and quality of life score before and after treatment were observed in both groups, and the total effective rate was evaluated as well.
      Results  The hiccup scores at 3 and 7 days of treatment in the press-needle group were significantly lower than those in the control group (P < 0.05). At 7 days of treatment, the total clinical effective rate in the press-needle group was 93.8%, which was significantly higher than 71.0% in the control group (P < 0.05). At 7 days of treatment, the scores of quality of life such as spirit status, sleep and diet in the press-needle group were significantly higher than those in the control group (P < 0.05). The adverse reactions in both groups were less and the symptoms were mild.
      Conclusion  Press-needle in auricular points combined with acupoints is effective in the treatment of intractable hiccup caused by chemotherapy for lung cancer, which can improve the quality of life of patients.

     

/

返回文章
返回